EPHA2 and breast cancer: Thus, we analyzed co-expression of ephrin-A1, the primary ligand for EphA2, and EphA2 protein in a large Stage I prognostic TMA from the NCI Cooperative Breast Cancer Tissue Resource (CBCTR) Cancer Diagnosis Program (CDP).